Lionheart Health, Inc. operating Lionheart Longevity & Wellness Clinics, a company focused on organ regeneration, medical aesthetics and healthspan longevity technologies, today announced it will be presenting at the 2025 The Science of Longevity themed Octane Medical Innovation Forum October 28th and 29th, 2025 in Irvine, California.

The Octane Medical Innovation Forum brings together industry experts, entrepreneurs, investors and thought leaders for two days of learning, networking and innovation on the latest insights and trends in the medical industry. For more information, visit the event website here https://www.octane-oc.org/event/omif/agenda

Howard Leonhardt, Executive Chairman & co-Chief Executive Officer of Lionheart Health, Inc., will present the latest developments of their technology platform focused on regenerative aesthetics and healthspan longevity.

The Company’s first-in-class technology platform utilizes precise patented bioelectric signaling sequences to cause release of regeneration promoting proteins upon demand. These include controlled expression of klotho a protein identified to be a key part of aging management. One patented signaling sequence controls stem cell recruitment, proliferation and differentiation on demand.

Lionheart Health's business model is to license and support thriving clinics worldwide with its's patented technology platform in exclusive territories. They have one clinic in Newport Beach, CA and 7 other licensed locations with many more licensed sites in the works. Their goal is to have 124 licensed locations up and running within the next 60 months.

The company was named earlier this year a top 40 semi-finalist in the XPRIZE Healthspan Competition out of 600 entries. This competition is focused on improvements in muscle health, brain health and immunity health with an eye goal on increasing healthy living years by 20 years. They are now working to make it to the next stage as a top 10 finalist. Earlier this month they won recognition from Medtech Outlook Magazine at the Top Micro Stimulator Implant Development of 2025 and were a finalist in the Orange County Business Journal's Innovator of the Year Award. Now this month they are a finalist in the Octane High Tech Awards in the Medical Innovation category with the awards ceremony set to be held the week September 25th. In December 2023 they won the coveted Abbvie Allergan ULP Golden Passport Award recognizing innovation in medical aesthetics.

The grandest project of Lionheart Health under development is a whole body regeneration chamber, womb for adults. The company is building an testing prototypes now with intent to release first a version utilizing only non-invasive technologies and then to follow later with a version that uses advance robotics, AI and implantable pump and stimulation technologies to regenerate internal organs. The latter is being developed with expert partners in each discipline.

Last month the company announced a special partnership with CoreViva based in Orange County for AI enhanced MRI for diagnostics. The company has been a long standing lab resident of University Lab Partners and the UCI Beall Applied Innovation Center Prototyping Lab in Irvine and has won multiple UCI Capstone Grants over the years including one for Brain Band TM its bioelectric stimulation technology platform for brain health.

Lionheart Health, Inc. is a 2022 spin out of Leonhardt Ventures LLC formed in 1982 focused on healthspan longevity and regenerative aesthetics. Leonhardt inventions have treated more than 600,000 patients to date.

Forward Looking Statements

Some of the statements in this release are “forward-looking statements,” which involve risks and uncertainties. Such forward-looking statements can be identified by the use of words such as “should,” “might,” “may,” “intends,” “anticipates,” “believes,” “estimates,” “projects,” “forecasts,” “expects,” “plans,” and “proposes.”

Although Lionheart Health, Inc. believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading “Risk Factors” and elsewhere our private placement memorandum . Forward-looking statements speak only as of the date of the document in which they are contained and Lionheart Health, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law.

Contact Information:

Brian Hardy
brian@lionhearthealthstim.com
Lionheart Health, Inc.
Leonhardt Ventures LLC

Research Clinic & Training Center

4740 Von Karman, Ste 150
Newport Beach, CA 92660
http://www.leonhardtventures.com
http://www.lionhearthealthstim.com
http://www.lionheartlongevity.com

R&D Lab

5270 California Avenue
Irvine, CA 92617

Office Headquarters

21010 Pacific City Cir #1406
Huntington Beach, CA 9248

This contant was orignally distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Lionheart Health to Present at the 2025 Octane Medical Innovation Forum - The Science of Longevity.